Resistance of HBV to adefovir dipivoxil: A case for combination antiviral therapy?
Open Access
- 30 December 2003
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 38 (6), 1584-1587
- https://doi.org/10.1002/hep.510380633
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis BHepatology, 2003
- Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter MutantsJournal of Virology, 2003
- Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHepatology, 2002
- Burden of liver disease in the United States: Summary of a workshopHepatology, 2002
- Long‐Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis InfectionThe Journal of Infectious Diseases, 2001
- Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionHepatology, 2001
- Efficacy of Long-Term Lamivudine Monotherapy in Patients With Hepatitis B e Antigen–Negative Chronic Hepatitis BHepatology, 2000
- Combination therapy with lamivudine and famciclovir for chronic hepatitis B–infected Chinese patients: A viral dynamics studyHepatology, 2000
- Combination chemotherapy for hepatitis B virus: The final solution?Hepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999